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ABSTRACT  Mouse mammary epithelial cells, of the normal rouTine mammary  gland (NMuMG) 
cell  line,  bear  a heparan  sulfate-rich  proteoglycan  (HSPG) on  their surfaces. A  hybridoma 
(281-2)  secreting a monoclonal antibody that recognizes  this HSPG was produced by fusion 
of SP-2]0 myeloma cells with spleen cells from rats immunized with NMuMG cells. The 281- 
2  monoclonal  antibody  is  directed  against  the  core  protein  of the  cell  surface  HSPG, as 
demonstrated  by (a) recognition of the isolated  proteoglycan but not its glycosaminoglycan 
chains,  (b)  co-localization  of 281-2-specific  antigen  and  radioactive  cell  surface  HSPG on 
gradient polyacrylamide gel electrophoresis and on isopycnic centrifugation, and (c) abolition 
of immunofluorescent staining of the NMuMG cell surface by the intact, but not the protease- 
digested ectodomain of the cell surface HSPG. The antibody is specific for cell surface HSPG 
and  does  not recognize  the  HSPG that accumulates  extracellularly  beneath  the  basal cell 
surface.  Therefore, the 281-2 antibody may be used to isolate the cell surface  HSPG and to 
explore its distribution in tissues. 
Interactions  of cells  with  extracellular  materials  are  likely 
mediated by cell surface matrix receptors (44).  Among these 
are cell surface heparan sulfate proteoglycans (HSPGs) t (25, 
34).  These  molecules,  consisting of a  core  protein  bearing 
polyanionic  heparan  sulfate  glycosaminoglycan  (GAG) 
chains, are found at or near the surface of all adherent cell 
types (16). Cell surface HSPG may exist in two forms, either 
bound to the cell surface via the GAG chains (21)  or inter- 
calated into the plasma membrane via the core protein (22, 
27,  34).  There are also extracellular matrix forms of HSPG, 
found in parenchymal cell  basement membranes (14)  or in 
the pericellular matrices of fibroblasts (15). 
We describe a  monoclonal antibody directed against the 
core protein of an HSPG that is intercalated into the plasma 
membrane of mouse mammary epithelial cells of the normal 
murine mammary gland (NMuMG) cell line. The GAG com- 
position, size, buoyant density, and/or resistance to reduction 
J  Abbreviations used in this paper: DME, Dulbecco's modified Eagle's 
medium; FCS, fetal calf serum; GAG, glycosaminoglycan; GdnHC1, 
guanidine-hydrochloride; HSPG(s), heparan sulfate proteoglycan(s); 
NMuMG, normal murine mammary gland; PG(s), proteoglycan(s); 
TBS, Tris-buffered saline. 
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appear to  distinguish  this HSPG  from some other cellular 
HSPGs such as those from rat hepatocytes (29), a hepatoma 
cell line (30), human fibroblasts (3, 5), bovine or rabbit aortic 
endothelial cells (2, 31), or human colon carcinoma cells (17), 
and also from those isolated from basement membranes, such 
as from the mouse EHS tumor (10,  14) and the rat kidney 
glomerulus (19,  39).  Indeed, the chemical characteristics of 
each of these HSPGs appear to differ from the others in some 
respect.  Despite  these  apparent  differences,  the  various 
HSPGs that have been isolated have not been compared to 
the extent that their relationships are conclusively established. 
Based on immunological reactivity (14,  17, 30, 39, 43), some 
HSPGs  may  be  similar,  or  perhaps  the  antibodies  detect 
similar determinants on distinct  HSPGs. To characterize a 
single type of HSPG immunologically, more specific immu- 
noglobulins, such as monoclonal antibodies, may be required. 
A part of this study was presented in abstract form (1). 
MATERIALS  AND  METHODS 
Cell Culture and Labeling 
NMuMG mouse mammary epithelial cells were obtained and cultured in 
bicarbonate-buffered Dulbecco's modified Eagle's medium (DME" Gibco Lab- 
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Tissue  Culture  Biological, Tulare,  CA) as described  previously  (7,  34). For 
labeling, confluent  monolayers  on plastic substrata  (usually  100-ram dishes; 
Falcon Labware, Oxnard, CA) were incubated in low sulfate medium containing 
100  U/ml penicillin  G,  50  ug/ml streptomycin  sulfate, and  100 ttCi/ml  of 
carrier-free H2a~SO4 (New England Nuclear,  Boston, MA) for 24 h, a period 
sufficient for the cells to reach a steady state level of a5so4 incorporation  (6). 
Preparation of HSPGs 
TOTAL PROTEOGLYCANS:  Total  cellular and  basal extracellular  pro- 
teoglycans (PGs) were isolated from cells cultured  on collagen gels that were 
adsorbed to polyamine  polyacrylamide beads (Affi Gel 731; Bio-Rad Labora- 
tories, Richmond,  CA). Type I collagen purified from rat tail tendons (4) and 
solubilized in 0.1  M acetic acid was adjusted to pH 5.7 with  1 M NaOH and 
incubated  overnight with beads (~4 mg collagen per 1 g of beads). The beads 
were washed with  10 mM phosphate-buffered  saline (PBS), pH 7.4 to remove 
non-bound collagen. Cells (-1.8-2.0  ×  106) suspended  by trypsin treatment 
were mixed with  1.4 g of beads in  I  0 ml of DME containing  10% FCS for 30 
min at room temperature.  The beads and cells were plated into 175-cm  2 culture 
flasks (20 total) and incubated at 37"C without  mixing. Medium was replaced 
on the first day to remove non-bound ceils and then on alternate days, On day 
7, two flasks were labeled with H235SO4 (25 uCi/ml),  and on day 8, the beads 
were harvested by settling. The beads were extracted by incubation  (for 8 h at 
4"C) in 4 M guanidine-hydrochloride (Gdn-HCI; Schwarz-Mann, Spring Valley, 
NY) containing  50 mM sodium acetate (pH 5.5), 0.5% Triton  X-100, and the 
following proteinase  inhibitors:  5 mM EDTA,  5 mM benzamidine  (Aldrich 
Chemical Co., Milwaukee, Wl), 5 mM N-ethylmaleimide (Calbiochem-Behring 
Corp.,  La Jolla, CA), and  1 mM phenylmethylsulfonyl fluoride (Calbiochem- 
Behring Corp.).  The 500 g supernatant was boiled and dialyzed against 8 M 
urea (Schwarz-Mann) containing  50 mM sodium acetate, pH 4.5 and 0.2 M 
NaCI, and was purified on a DEAE-Sephacel column as described below. 
BASAL EXTRACELLULAR AND  CELL SURFACE  PGS:  PGs  depos- 
ited beneath the cell monolayer (basal extracellular PG) and the ectodomain  of 
the cell surface PG were prepared from confluent  monolayers after they were 
labeled with radiosulfate. The medium was discarded, and the monolayers were 
washed twice with cold Tris-buffered saline (TBS; l0 mM Tris, pH 7.4, 150 
mM NaC1 containing  1.25 mM CaCI2 and 0.9 mM MgSO4). The monolayers 
were scraped with a rubber policeman into cold TBS-EDTA (0.5 mM EDTA) 
containing  the  following proteinase  inhibitors: 0.5 mM phenylmethylsulfonyl 
fluoride,  5 mM benzamidine,  and  5 mM N-ethylmaleimide.  The cells were 
centrifuged (200 g) and the supernatant,  containing the basal extracellular PG, 
was brought to 8 M urea or 4 M GdnHCl,  buffered as above, and boiled. 
The ectodomain  of the cell surface PG was prepared by trypsin treatment  of 
the cells (35). The cell pellet was washed four times in cold TBS-EDTA, and 
suspended by gentle agitation. Bovine pancreatic trypsin (2x crystallized, type 
ill:  Sigma  Chemical  Co.,  St.  Louis,  MO)  was added  to  20  ug/ml and  the 
mixture incubated at 4*C for 5 min. After 100 ug/ml soybean trypsin inhibitor 
(Sigma Chemical Co,) was added, the cells were centrifuged again, leaving the 
ectodomain  of the cell surface PG  in the supernatant.  This supernatant  was 
brought to 8 M urea and purified over DEAE-Sephacel as described below. 
PURIFICATION  AND  ANALYSIS OF  PGS:  PGs  were adsorbed  on a 
column (1  × 5 cm) of DEAE-Sephacel (Pharmacia  Inc., Piscataway, N  J) in 50 
mM sodium acetate (pH 4.5) containing  8 M urea and 0.2 M NaCI, washed 
with the same buffer, and eluted with a linear gradient of 0.2-0.8  M NaCI in 
this solution.  Both the basal extracellular PCJs and the ectodomain  eluted as a 
single peak of 35SO4-1abeled material at 0.5-0.6  M NaCI. The labeled material 
was either  precipitated  by mixing  with 4  vol ethanol  at -20*C followed by 
centrifugation,  or stored in 8 M urea at -20"C. The 35S-ectodomain prepared 
and  purified  in  this  manner contains  all  the  GAG  chains,  but  lacks  the 
hydrophobic  domain and is slightly smaller than the  parent  cell surface PG 
(24. 35). 
Cellular  and basal extracellular  PGs in  50  mM sodium acetate  (pH 4.5) 
containing  4  M GdnHCI and  1%  Triton X-100 were analyzed by isopycnic 
centrifugation.  Samples  were  brought  to  1.4  g/ml  with  crystalline  CsCI 
(Schwarz-Mann  Biological Grade) and centrifuged at  15"C for 72 h at 46,000 
rpm in a Beckman SW 65 rotor (Beckman Instruments, Inc., Palo Alto, CA). 
Fractions  were  collected  and  analyzed  for  density  by  weighing. Total  PG 
radioactivity was assessed by modification  of the procedure  of Stephens et al. 
(38). Cetylpyridinium chloride-impregnated  Whatman 3MM filter discs (What- 
man  Inc.,  Clifton,  N  J) were  prepared  by  soaking  in  2.5% cetylpyridinium 
chloride followed by drying. Aliquots were spotted on the dry discs which were 
washed five times in distilled water, soaked for 1 h in 25 mM sodium sulfate, 
and rinsed several times in distilled water. Finally, the discs were soaked for 30 
min in  10%  trichloroacetic  acid (TCA) followed by washes in distilled water 
and 95% ethanol and were dried for scintillation counting. 
PG relative mass was assessed by gradient  PAGE (described below) or by 
Sepharose CL-4B (Pharmacia  Inc.) chromatography  in 4 M GdnHCI buffered 
to pH 5.5 by 50 mM sodium acetate, or in  1% SDS, 100 mM NaCI buffered 
to pH 8.0 with 50 mM Tris-HC1. Radioactivities in solutions were assayed by 
scintillation counting  using 6 vol of Aquamix (West Chemical Products, Inc., 
New York, NY) for each sample volume. Samples containing  4 M GdnHCI 
were diluted  1:10 with water before mixing with Aquamix, 
Characteristics of  the PGs were investigated by various treatments. PGs were 
(a) treated with 0.5 M NaOH, 0.1 M NaBH4 for 18 h at 37°C to remove GAG; 
(b) digested with papain ( 1 mg/ml, Worthington  Biochemical Corp. Freehold, 
N  J) in  5 mM cysteine-EDTA pH 7.5  for 24  h at 60°C to degrade the core 
protein;  (c)  treated  with  heparitinase  (0.1 U/ml;  Miles Laboratories,  Inc., 
Naperville, IL) in 50 mM Tris, pH 7.0 and 5 mM calcium acetate for 3 h at 
37"C to digest heparan  sulfate or; (d) with chondroitin  sulfate ABC lyase (0.5 
U/ml; Miles Laboratories,  Inc.) in 50 mM Tris, pH 8.0 and 30 mM sodium 
acetate  to digest chondroitin  and  dermatan  sulfates. Both  Tris  buffers also 
contained 0.1  mg/ml bovine serum albumin (BSA) and 1 mM phenylmethyl- 
sulfonyl fluoride. 
Preparation of Monoclonal Antibodies 
IMMUNIZATION AND PRODUCTION OF HYBRIDOMAS;  Confluent 
NMuMG  cells were  washed  three  times  with  cold  PBS  and  the  cultures 
harvested by scraping with a rubber policeman.  An aliquot of this suspension 
(0.25 ml in PBS) containing ~4 x  l0  7 cells was combined with an equal volume 
of Freund's complete adjuvant and injected into two hind foot pads of ~30-d- 
old Fisher rats. The rats received an identical inoculum intraperitoneally twice 
more at  10-d intervals.  10 d after the second intraperitoneal  injection,  blood 
samples were taken, and sera were tested for reactivity against PGs (see below). 
Rats with reactive serum received a third  intraperitoneal  injection  3 d before 
their spleens were harvested. 
For hybridoma production,  a single cell suspension of rat spleen cells (107/ 
spleen) (37) was mixed  (1:1) with  log phase  mouse SP-2/0  myeloma  cells 
(kindly  provided  by  Dr.  I.  Weissman,  Department  of Pathology,  Stanford 
University) in 38% polyethyleneglycol 1540 (J. T. Baker Chemical Co., Phil- 
lipsburg, NJ) for fusion. The cells were grown on multidish  12-ram plates at 4 
×  l0  s cells/cm 2 in  HAT-DME  containing  20%  FCS as described elsewhere 
(1 I). Hybridoma supernatants  were screened by a solid phase radioimmunoas- 
say as described below. Selected hybridomas were cloned, then subcloned by 
limiting dilution and assessed for antibody production by immunodot assay as 
described below. 
PRODUCTION  AND  PURIFICATION  OF  MONOCLONAL  ANTI- 
BODIES: Selected  subelones  of hybridoma  281-2,  a  hybrid  producing  an 
antibody specific for HSPG (see Results), were cultured in serum-free medium 
and as ascites in splenectomized  nude mice. Hybridoma cells (4 x  105/cm  2) 
were plated onto 100-ram dishes (Falcon Labware) in HB 101  medium (Hana 
Biologics, Berkeley, CA) without serum, and medium was harvested every 4 d. 
The immunoglobulins  in this medium were precipitated overnight at 4"C after 
slowly adding  ammonium sulfate  to  50%  saturation.  The  precipitate  was 
collected at 10,000 g, as described by Hardy (13), dissolved in TBS, and dialyzed 
against TBS. 
For the production  of ascites fluid, athymic  nude  BALB/c mice (Harlan 
Sprague Dawley, Inc.,  Indianapolis,  IN) were spleneetomized,  and 2 d later 
received a 0.5-ml i.p. injection of 2, 6, 10,  14-tetramethyl pentadicane (Aldrich 
Chemical Co.).  1 wk later, l0  T  hybridoma  cells in 0.5 ml DME were injected 
intraperitoneally,  and aseites fluids were harvested 7-10 d later. Immunoglob- 
ulins in clarified ascites fluids (25 ml) were isolated by diluting  1:1  with TBS 
and precipitating as described above. The precipitate was dissolved in TBS and 
desalted over a Sephadex G-25 column (Pharmacia Inc.) in TBS. 
The immunoglobulins from both procedures were further purified by mixing 
with QAE-Sephadex (Pharmacia Inc.) in TBS for 3 h at 4°C, which was removed 
by centrifugation at 20,000 g for 30 rain, and the supernatants  containing the 
monoclonal antibodies (13) were stored at -70*C or in liquid nitrogen. Protein 
concentrations  were estimated  using BSA as a standard  (26). Concentrations 
and  type  of antibody  used  in  each  experiment  are  indicated  in  the  figure 
legends. 
Immunotechniques 
A S S A Y  F O R  R A T  S E R U M  A N T 1B O D I E S : Antibody with reactivity against 
PG was demonstrated  in rat serum by a Staphylococcus aureus-binding assay 
(12, 20). S.  aureus (Calbiochem-Behring Corp.) were washed three times by 
suspension and centrifugation  in 50 mM Tris-HCl, pH 8.3, 0.45 M NaCl, and 
0,5% Nonidet-P40 (Calbiochem-Behring Corp.), resuspended in the same buffer 
containing 0.1% BSA and rabbit anti-rat lgG (final concentration  400 ug/ml; 
Dako Corp.,  Santa  Barbara, CA), and incubated  for  1 h at 4"C. After three 
more washes and resuspension, the S.  aureus were incubated  with rat serum 
(l : l0 dilution) for 2 h. After removal of serum by similar washings, 5,000 cpm 
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Nonbound radioactivity was removed by washing, the pellet was suspended in 
2% SDS, boiled,  and the radioactivity  released  was measured by scintillation 
counting. 
SOLID-PHASE  RADIOIMMUNOASSAY:  Individual  wells  of  96-well 
plates (Flow Laboratories,  Inc., McLean, VA) containing 0.15 ml rabbit anti- 
rat  lgG (final  concentration 2  mg/ml in TBS;  Dako Corp.) were incubated 
overnight at 4°C. The lgG was replaced with TBS containing 0.5% BSA (BSA- 
TBS) for  1 h  at  room temperature, and the wells were  filled  (200  ul) with 
hybridoma medium and incubated overnight at 4"C. After washing the wells 
three times with  BSA-TBS,  5,000-6,000 cpm of 35S-labeled PG in 0.15  ml 
BSA-TBS was added and incubated overnight at 4"C. After washing as in the 
previous step, the wells were removed by trimming with a hot wire, and each 
well was counted by liquid scintillation. 
IMMUNODOT  ASSAY  ON  DEAL-PAPER:  Similar  sized  pieces  of 
DEAL-cellulose  paper (Whatman DE 81) and Whatman 3 MM paper (What- 
man Inc.) were wet with TBS and placed in a Microfold-dot apparatus (V & P 
Scientific,  San Diego,  CA) such that the 3 MM paper underlaid the DEAL- 
paper.  Antigen in 8  M  urea buffered to pH 4.5  by 50 mM sodium acetate 
(usually 0.1-4 ug PG protein in 200 ~1) was applied through the apparatus 
wells onto the paper, followed by washing 5-6 times with TBS under vacuum 
without letting the paper dry. The antibody preparation (culture medium or 
antibody diluted in TBS) was either similarly applied to and washed off the 
paper, or incubated batchwise  overnight at 4"C with the DEAL-paper which 
had been previously incubated at room temperature for 10 rain with 1% FCS 
in TBS. After either antibody treatment, the DEAL-paper in a dish was washed 
5-6 times in TBS and incubated with peroxidase-conjugated rabbit anti-rat 
IgG (final dilution 1:200 in TBS containing 1% FCS; Dako Corp.) for 30 min 
with gentle shaking. The paper was then washed for 20-30 min by shaking 
with 5-6 changes of TBS. Binding of the peroxidase conjugate was visualized 
using 0.05%  (wt/vol) 4-chloro-l-naphthol (Sigma Chemical Co.)  containing 
0.03%  (vol/vol) hydrogen peroxide in TBS (8). 
SOS  PAGE  AND  WESTERN-BLOTTING  ON  DEAE-CELLU- 
LOS E: Proteins were fractionated in a gradient (3.8-20.0%) polyacrylamide gel 
using PAGE buffer composed of 40 mM Tris, 60 mM boric acid,  0.8 mM 
EDTA,  1 mM Na2SO4, and 0,1%  SDS.  The linear gradient gel was formed 
from 3.8 and 20% acrylamide solutions containing 7.5% bisacrylamide, 2.6 M 
urea, and 0.2 and  I  M  glycerol,  respectively.  The gel was run overnight to 
completion at  125 V in a Hoefer SE 500 apparatus (Hoefer Scientific  Instru- 
ments, San Francisco, CA) in PAGE buffer. The sample loading buffer consisted 
of the PAGE buffer containing 2%  SDS,  0.5  M  glycerol,  and bromophenol 
blue (0.01 mg/ml). After the run, the gel was transferred onto a pad of a Hoefer 
TE 52 transfer apparatus and covered with DEAL-cellulose  paper soaked with 
distilled  water and supported by Whatman 3  MM paper. Transfer was per- 
formed according to Towbin et al.  (40)  at  100 V for 6 h. The antigen was 
localized  by  indirect  enzyme  immunostaining as  described  above  for  the 
immunodot assay. For autoradiography, the gel was fixed in  10% TCA-50% 
methanol, washed in methanol/acetic acid/water (5:7:88) for 3 h, set overnight 
in 50% methanol, and developed for silver staining (28). The dried gel (Bio- 
Rad gel dryer,  Bio-Rad Laboratories)  was exposed to Kodak X-Omat XAR-5 
film at -70"C. 
ISOELECTROFOCUSING  AND  IMMUNODETECTION  OF  RAT  IMMU- 
N  O  G LO a U L l N S  : The purified antibody preparations were electrofocused  in a 
0.5-ram polyacrylamide gel (2%)  with the pH  range 3.5-10.0 (ampholytes; 
LKB Instruments, Inc., Gaithersburg, MD) in an LKB Multiphor horizontal 
apparatus, as described elsewhere  (18). After the run, the pH scale of the gel 
was measured using a surface electrode,  then part of the gel was processed for 
Coomassie Blue staining, as described  by the manufacturer, and proteins from 
the other part of the gel were transferred onto nitrocellulose  paper (18).  Rat 
immunoglobulins  were detected as described  above for the immunodot assay 
with the exception that the nitrocellulose  paper was treated with 0. 1% Tween- 
20-TBS for l h after the transfer. 
IMMUNOSTAINING  OF  CELLS:  NMuMG cells were cultured on cover- 
slips, washed three times with cold PBS, and incubated first with normal rabbit 
IgG  (final  concentration  100  #g/ml  in  PBS;  Cappel  Laboratories,  Coch- 
ranville~ PA) in an ice bath for  10 min. The monolayers were  then washed 
three times with cold PBS and incubated with 281-2 antibody for 30 rain on 
the ice bath. After the monolayers were washed five times with PBS, they were 
fixed in ice cold 30, 70, and 100% acetone each for 1 rain, rehydrated back in 
the same solutions, and finally for l0 min in PBS. Monolayers were exposed 
to fluorescein isothiocyanate-conjugated rabbit anti-rat IgG (1:50 dilution in 
PBS; Dako Corp.) for 30 rain, washed five times with PBS, covered with 2.4% 
n-propylgallate  in 100% glycerol, and viewed with epifluorescence. 
RESULTS 
NMuMG  cell cultures contain  HSPGs  within the cells, at the 
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cell  surface,  and  extracellularly  beneath  the  monolayer  (6, 
35). These PGs are apparently heterogeneous in size, buoyant 
density,  and  lipophilicity  but  have  the  same  charge  density 
and  types  of GAG,  suggesting that  they  may  differ  only  in 
their core protein. To assess this possibility, we have attempted 
to  prepare  monoclonal  antibodies  specific  for  the  different 
PG  types, and  here report  on the preparation  of an antibody 
directed against the core protein of the cell surface PG. 
Induction and Screening of 
Monoclonal Antibodies 
Rats were immunized with a fraction containing both whole 
cells and the material accumulating beneath NMuMG mon- 
olayers.  Spleen cells from these rats were fused with SP-2/0 
myeloma  cells.  In  one  fusion,  resulting  in  188  wells  that 
contained successful hybrids, media from 28 were positive, as 
assessed by a solid phase radioimmunoassay for total PGs (see 
Materials  and Methods). The cultures of positive clones were 
expanded, then screened again, and four reactive clones (209, 
230, 281, and 349) were selected (Fig.  1). The most positive 
(281) of these was evaluated further after cloning by limiting 
dilution.  The subclones of 281  were assayed  again  with the 
total PG  preparation  as well as with the purified ectodomain 
of the cell  surface PG.  Using these assays, five  subclones of 
281  were  selected  that  showed  reactivity  against  both  these 
preparations (data not shown). However, since antigenic reac- 
tivity may be lost because of subculturing, the selected clones 
were maintained  in culture for 6 wk before recloning to ensure 
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HYBRIDOMA CLONES 
Hybridoma clones recognize 35SO4-1abeled  PG. Purified 
35SO4-1abeled PGs were added (5,000 cpm/well) to wells previously 
coated  first  with  rabbit  anti-rat  IgG  and  then  with  various  hy 
bridoma media (see text). Each bar represents  the average in two 
independent assays for the amount of 35SO4-1abeled  PG bound by 
media from hybridoma clones.  The positive clones are indicated 
(209, 230, 281, and 348). that they were stable. A single done, 281-2, was selected for 
further characterization. 
Characterization of Clone 281-2 
Analysis of PG-specific antibodies  was  facilitated  by  an 
immunodot assay in which PGs were immobilized on DEAE- 
cellulose paper by the binding of their GAG chains. Use of 
DEAE-cellulose paper was necessary as the PG did not bind 
well to either nitrocellulose or aminophenylthioether paper, 
possibly due to its extensive glycosylation. Reactivity in the 
assay, shown using medium from clone 281-2 cultures, was 
dependent on both the antigen concentration and the dilution 
of hybridoma medium  (Fig.  2).  The  assay was sufficiently 
sensitive to detect reactivity in a  1:1,000  dilution of culture 
medium and with 10 ng of PG protein per dot (Fig. 2). Thus, 
clone 281-2  is a  satisfactory producer,  and  the  PG  can be 
detected when bound to DEAE-paper. 
Clone 281-2 was recloned by limiting dilution.  Using the 
immunodot  assay,  35  out  of  36  subclones  were  positive, 
suggesting that 281-2 was monoclonal. Two of the subclones 
(281-2-17 and 281-2-28) were selected for large scale produc- 
tion of antibodies by culture in serum-free medium and for 
the preparation of ascites fluid in nude mice. The 281-2 clone 
and its subclones produced an IgG2a rat immunoglobulin as 
shown by dot assay and indirect immunoassay on nitrocellu- 
FIGURE  3  Isoelectric focusing of 
antibody  281-2.  Ascites-derived 
281-2 was loaded (5 gg/lane) onto 
a 2% polyacrylamide gel and fo- 
cused  as  described  in  the  text. 
Identical  lanes  were  processed 
for  protein  stain  (lane  A)  or  for 
immunodetection  of  rat  immu- 
noglobulins (lane B) after transfer 
onto  nitrocellulose  paper  (see 
text), pH gradient is indicated on 
the right. 
FIGURE  2  Antibody produced by hybridoma 281-2 recognizes PG 
immobilized on  DEAE-cellulose  paper.  PG  was  bound  to  DEAD 
cellulose  paper.  (A  and  B)  0.001-4  /~g protein  per  dot;  (C)  4  /~g 
protein  per dot. A  constant volume  {400  /~1} of antibody (culture 
medium from  281-2  hybridoma cultures) either undiluted  (A),  di- 
luted up to 1:1,000 {C), or unconditioned culture medium contain- 
ing  20%  FCS  (B)  were eluted  through  the  dots.  Bound  IgG  was 
detected by a peroxidase-conjugated rabbit anti-rat IgG (see text). 
lose  paper (not  shown),  using  class-specific  rabbit  anti-rat 
antibodies (kindly provided by Dr. R. Coffman, DNAX, Palo 
Alto,  CA).  The  subclones  produced  antibodies  that,  after 
purification (13), showed only a single major band on isoelec- 
trofocusing by both protein stain  and  immunostain for rat 
immunoglobulins (Fig. 3, lanes A and B, respectively). Thus, 
the 281-2 antibody appears to be monocional (33). The isoe- 
lectric point of 281-2  was 8.6,  which  is unusually high  for 
immunoglobulins, but typical for monoclonals (33). This high 
isoelectric point facilitated the use of 281-2 in immunoassays 
on DEAE-paper because its low binding to DEAE produced 
low backgrounds. 
Characterization of the Antigen 
The antigenic determinant recognized by 281-2 may reside 
in the PG core protein or its GAG chains. To assess whether 
the GAG chains were reactive, total 35S-PG was treated with 
either alkaline borohydride, to cleave the GAG chains from 
the protein, or papain, to destroy the protein. These digests 
were applied directly to DEAE-paper for immunoassay and 
autoradiography. Alkaline borohydride, papain-digested, and 
untreated materials showed identical radioactive patterns on 
DEAE-paper (Fig.  4),  indicating that the digestions did not 
affect the binding of the GAG to the DEAE-paper. However, 
when  this  sheet was  immunostained  with  281-2,  only un- 
treated samples gave a positive signal (Fig. 4), suggesting that 
the 281-2 antibody does not recognize the GAG chains of the 
PG. 
If antibody 281-2 is directed against the PG core protein, 
the  immunoreactive material  should  co-distribute with  the 
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that reacts with antibody 281-2,  cellular and basal extracel- 
lular 35S-PGs were fractionated according to  their buoyant 
densities  using  isopycnic  centrifugation.  Extracts  of  cells 
showed a single major 3~S peak with a density of 1.45-1.55 g/ 
ml  (Fig.  6A),  corresponding  in  density  to  that  of the  cell 
surface PG (35).  This peak and  material of lower buoyant 
density were immunoreactive when dotted onto DEAE-paper 
and stained with 281-2.  The basal extracellular fraction was 
separated into three 35S-labeled PG peaks, of  buoyant densities 
>  1.55,  1.35-140,  and  1.25-1.28  g/ml  (Fig.  6B).  Despite 
levels of radioactivity similar to that of the cellular extracts 
when these fractions were stained for 281-2, immunoreactiv- 
ity was weak. The only stained material corresponded to the 
density of the immunoreactive material in the cellular frac- 
tion, presumably due to the presence of some residual cellular 
material. These data suggest  that antibody 281-2  recognizes 
cellular PGs, including possible PG precursors, but does not 
recognize any of the basal extracellular PG fractions. 
FIGURE  4  The antibody 281-2  does  not  recognize GAG  chains 
immobilized on DEAE-cellulose.  Total monolayer PG, ranging from 
0 to 8 #g, was bound to DEAE-cellulose  paper without any further 
treatment (A), after an  18-h incubation in TBS at 37°C (B), after an 
18-h incubation in 0.5 M  NaOH/0.1  M  NaBH4 at 37°C (C), or after 
a 24-h  papain digestion (100 #g/ml) in 5 mM cysteine-HCl, pH 7.5 
at 60°C (D). The paper was then incubated with monoclonal anti- 
body (purified medium-derived 281-2; 60/~g/ml). 35SO4-GAG bind- 
ing to the paper was assessed by autoradiography (AUTO),  and 281 - 
2 binding was detected with a peroxidase-conjugated rabbit anti- 
rat antibody (IMMUNO). 
35S-label but should decrease in size after removal of the GAG 
chains. This was assessed by urea-SDS PAGE of the purified 
35S-ectodomain,  followed  by transfer onto  DEAE-cellulose 
paper which  was immunostained  and  subjected  to  autora- 
diography. Because the cell surface PG is a hybrid containing 
both  heparan  sulfate  and  chondroitin  sulfate GAG chains 
(36),  samples were treated with buffer, heparitinase, or both 
heparitinase and chondroitin sulfate ABC lyase before electro- 
phoresis. By autoradiography, the untreated PG appears as a 
smear in the gel, with a modal relative mass of ~200-260 kD 
(Fig.  5, lane A). This smearing, typical of PGs, is due to the 
polydispersity of the GAG chains and is probably accentuated 
here  by the  use of proteolysis to  prepare  the  ectodomain. 
Immunostaining with 281-2 revealed that the antigen runs as 
a  similar  smear  (Fig.  5,  lane  A).  The  heparitinase-treated 
sample (Fig.  5, lane B), as expected, lost most of its radioac- 
tivity, and the remaining radioactive material was reduced to 
Mr -  80-110 kD. The immunoreactive material shifted in an 
identical manner and again displayed the same size distribu- 
tion as the radioactive material. Treatment with chondroitin 
ABC lyase together with heparitinase removed all detectable 
radioactivity, but an  immunoreactive band of M,  ~  70-80 
kD remained (Fig.  5, lane C), possibly representing the core 
protein.  Thus,  the  antibody 281-2  recognizes a  cell  surface 
PG containing both heparan and chondroitin sulfate chains. 
Cellular Localization of the Antigen 
Radiosulfate  is  incorporated  into  macromolecules  by 
NMuMG cells solely into PGs (7) that are found both with 
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FIGURE  5  Electrophoretic codistribution of the 3sso4-1abeled ec- 
todomain and the 281-2  immunostain of the cell surface  PG. The 
GAG-bearing ectodomain of the cell surface  PG (5 ~.g) was either 
not treated (lane A), treated with heparitinase (0.1 U/ml for 3 h at 
37°C) (lane B), treated with heparitinase and chondroitin ABC lyase 
(0.5 U/ml for 3 h at 37°C) (lane C) then run on gradient SDS PAGE 
and  transferred  to  DEAE-cellulose  paper.  DEAE-cellulose  paper 
transfers were assessed by autoradiography (AUTO)  and by immu- 
nostaining using purified medium-derived 281-2  at 60 ~.g/ml (IM- 
MUNO). Molecular weight estimates are based on the mobilities of 
the beta and alpha chains of type I collagen (9), BSA, ovalbumin, 
chymotrypsinogen A, and myoglobin. FIGURE  6  Cellular high density PG is recognized by 281-2. Cellular 
(A) and basal extracellular (B) PGs were fractionated in CsCl density 
gradients. Aliquots from gradient fractions were used to measure 
densities (- -  -}, to assess radioactivity in PG (0), or were bound to 
DEAE-cellulose paper after a 1:100 dilution with 50 mM Na-acetate 
(pH 4.5) containing 8 M  urea.  Bound  PG was detected by autora- 
diography (R) or by 281-2  immunostaining using purified medium- 
derived 281-2 at 60 #g/ml (/). 
The isolated ectodomain of the cell surface PG (Fig. 5) and 
a  cellular PG corresponding in  buoyant density to the cell 
surface  PG  (Fig.  6)  are  recognized by antibody  281-2.  To 
assess directly whether the antibody reacts with a cell surface 
antigen,  NMuMG  cells  were  stained  by indirect  immuno- 
fluorescence. Monolayers were incubated with 281-2 at 4"C 
before  fixation,  then  fixed  and  stained  with  a  fluorescent 
second antibody. Antibody 281-2 stains the apical cell surface; 
staining was especially intense where cells abutt one another 
(Fig.  7, A  and B) and was not seen with rat IgG (Fig.  7E). 
This staining was abolished by treating the  monolayer with 
trypsin (20 ~g/ml, 4"C,  10 min) (Fig.  7, C and D), suggesting 
that the antigen is at the cell surface. 
Competition on experiments with the purified ectodomain 
were performed to ascertain whether the cell surface antigen 
is the cell surface PG.  The ectodomain was incubated with 
281-2, the mixture centrifuged, and the supernatant used to 
stain monolayers. The ectodomain prevented the staining of 
NMuMG  cell  cultures  (Fig.  8A),  indicating  that  the  cell 
surface antigen is the cell surface PG. Sham-incubated ecto- 
domain (Fig.  8B) and a  mixture of core protein and GAG 
chains  prepared  by  treating  the  ectodomain  with  alkaline 
borohydride (Fig.  8 C) also prevented staining. However, pa- 
pain-digested samples failed to compete (Fig. 8 D), indicating 
that papain treatment destroys the antigenic site. These results 
suggest that antibody 281-2 recognizes a polypeptide antigen 
on the cell surface PG. 
DISCUSSION 
NMuMG  mouse  mammary epithelial  cells  contain  a  cell 
surface HSPG (34).  We have isolated a  monoclonal mouse- 
rat hybridoma clone 281-2 that produces antibodies against 
the core protein of this cell surface PG. The antigen detected 
by the antibody 281-2 is identical to the cell surface PG, as 
demonstrated by its size, buoyant density, and susceptibility 
to heparitinase and chondroitin sulfate ABC lyase, and by the 
specific staining of the surface of cultured NMuMG cells. The 
antibody binds to the PG core protein because removal of the 
GAG chains from the PG does not abolish binding, and PG 
devoid of its GAG chains is as effective as is untreated PG in 
competitively blocking the staining of NMuMG cells by the 
antibody. Extracellular PGs found beneath the NMuMG cell 
monolayer are distinct from the cell  surface PG in buoyant 
density and are not recognized by the antibody 281-2. Thus, 
281-2 is a specific probe for the core protein of the cell surface 
HSPG and can be used to study the metabolism of the core 
protein, the distribution of the PG in tissues,  and the role of 
the PG in cell behavior. 
Antibodies Directed Against HSPGs 
HSPGs are found intracellularly, in the extracellular matrix, 
and at the cell surface. Where examined, considerable diver- 
sity of PG structure exists between and within these classes 
(16).  Despite  these  apparent  differences,  polyclonal  serum 
antibodies  prepared  against  basement  membrane  and  cell 
surface  PGs  have  broad  specificity and  may  show  cross- 
reactivity. For example, an affinity purified antibody prepared 
against  the  HSPG  isolated  from  a  basement  membrane- 
producing tumor recognizes the  PG in the basement mem- 
branes of most, if not all, tissues studied (l 4), in the pericel- 
lular matrix of human fibroblasts (l 5), and on the surfaces of 
aortic endothelial (3 l) and intestinal epithelial cells (17).  A 
serum antibody directed against the HSPG of the glomerular 
basement membrane also recognizes kidney and liver epithe- 
lial cell surfaces (39).  Based on these immunological results, 
the HSPGs are either more similar than the size and compo- 
sitional data would suggest or the antibodies recognize some 
common determinant(s) on apparently dissimilar molecules. 
Because  monoclonal  antibodies  detect  only single  deter- 
minants, we have pursued the monoclonal antibody approach 
in an attempt to obtain a specific immunoprobe for the HSPG 
on the surfaces of cultured epithelial cells. Our approach was 
to use intact NMuMG cells as the immunogen, circumventing 
the  need to purify large amounts of this  PG,  and to use a 
radiochemically pure, soluble PG in a radioimmunoassay to 
screen for specific antibody production and to assist in char- 
acterizing the antigen at the cell surface. This PG is the ~sS- 
ectodomain  of the  cell  surface  PG,  readily  prepared  and 
purified from 35SO4-1abeled cells by mild treatment with tryp- 
sin followed by DEAE-cellulose chromatography  (35). Further 
analyses used DEAE-paper as a  solid support for the PG in 
an  immunodot assay and  for immunological  evaluation of 
electrophoretic transfers. DEAE-paper was used because the 
PG does not  bind to either nitrocellulose  or aminophenyl- 
JALKANEN ET  AL.  Monoclonal Antibody for Heparan Sulfate Proteoglycan  981 FIGURE  7  Trypsin removes the stain at the apical surface of NMuMG cells. Intact monolayers treated with or without trypsin (20 
/zg/ml, 4°C,  10 min) were incubated with purified ascites-derived  281-2  (60/~g/ml)  followed by detection with an fluorescein 
isothiocyanate-conjugated rabbit anti-rat IgG (see  text). (A) No trypsin treatment;  (B) phase contrast of A; (C) trypsin treatment; 
(D) phase contrast of C; (E) no trypsin treatment,  and a nonspecific  rat IgG (100/.tg/ml) was substituted  for 281-2. 
thioether paper, commonly used for Western blots (41).  Use 
of DEAE-paper allows the PG to be dissolved in high concen- 
trations of urea or in nonionic detergents during binding and 
enables  low  pH  to  be  used  to  elute  both  contaminating 
polypeptides or nonspecific immunoglobulins without eluting 
the PG. 
The Monoclonal Antibody 281-2 Is Specific for 
the Core Protein of Cell Surface HSPG 
281-2  recognizes  a  polypeptide  determinant  on  the  cell 
surface PG. The 281-2 reactive determinant was identified as 
the core protein of the cell surface PG by observing the effects 
of treating the  PG with alkali,  protease, or selective GAG- 
degrading enzymes. Immobilization and immunodetection of 
protease-  or  alkali-treated  35S-ectodomain  on  DEAE-paper 
indicate  that although  the GAG chains  remain bound,  the 
281-2 reaction site has been lost.  When the 35S-ectodomain 
was fractionated by gradient SDS PAGE, either intact or after 
removal  of GAG  chains  with  heparitinase  or  chondroitin 
sulfate ABC  lyase,  then  transferred onto  DEAE-paper and 
stained  for 281-2,  identical  profiles were  revealed by both 
autoradiographic and  immunological detection.  These data 
suggest  that the antibody-binding site does not reside in the 
982  THE  JOURNAL OF  CELL BIOLOGY • VOLUME 101,  1985 
GAG chains and that the antigen  recognized by 281-2  and 
the 35S-ectodomain  are identical regardless of whether either 
type of GAG chain is removed. These data also confirm the 
finding that the cell surface PG is a  hybrid, containing both 
heparan  and  chondroitin  sulfate  chains  on  the  same  core 
protein (36). 
The  monoclonal  antibody  stains  the  apical  surfaces  of 
cultured subconfluent NMuMG cells. This stain is specific for 
the cell surface PG because the purified ectodomain competes 
with  the  cell  surface  staining.  The  site  recognized  by  the 
monoclona1281-2 on the cell surface is a polypeptide, because 
papain digestion  destroys the  ability of the  ectodomain to 
compete. These data suggest  that N-linked oligosaccharides, 
known to exist on heparan sulfate PGs (32, 45),  are not part 
of the antigenic site recognized by 281-2. 
The core protein determinant is not found on extracellular 
PGs.  NMuMG  cells  produce  a  basal  lamina-like structure 
rich in HSPG when grown on type I collagen gels (6, 7). These 
PGs are deposited beneath the monolayers when the cells are 
grown on plastic, contain a basement membrane PG (7), and 
can be harvested by scraping and centrifuging the cells, leaving 
the basal extracellular PGs in  the supernatant (7,  23).  This 
fraction contains  three  pools of PG  that  differ in  buoyant 
density from each other and from the intact cell surface PG FIGURE  8  The ectodomain of the cell surface PG 
competes with  NMuMG  cells for antibody 281-2. 
Purified  ascites-derived 281-2  (12  /~g/ml)  was  in, 
cubated  for  30  rain  at  room  temperature  with 
purified ectodomain previously (A)  untreated, (B) 
incubated  in  TBS, (C) treated with  alkaline/boro- 
hydride, or (D) digested with papain, prepared as 
in the legend to Fig. 4. The mixtures were centri- 
fuged (10,000 g), and the supernatants were used 
to stain intact monolayers as described in the text. 
(Fig.  6).  Although  the intact cell surface PG  was detected by 
antibody  281-2  in  this  fraction,  all  three  basal  extracellular 
PG pools were negative. Thus, the 281-2 reactive determinant 
is either masked or not present in the basal extracellular PGs. 
The masking may be due to extracellular processing of HSPG 
or, despite the presence of 8  M  urea and previous extraction 
with  4  M  GdnHCI,  interaction  of  the  HSPG  with  other 
extracellular  matrix  molecules  (10,  42).  The  HSPGs  accu- 
mulating  beneath  the  NMuMG  cells  may  be  products  of a 
gene  not  coding  for  the  281-2  polypeptide  determinant.  In 
that case, the NMuMG  cells can produce both a  cell surface 
HSPG  and a  basement membrane  HSPG,  and antibody 281 - 
2  distinguishes between these two types of PG. 
The antibody 281-2  will be used to explore the function of 
this cell surface HSPG  in cell anchoring, matrix organization, 
and  the control  of organ  development,  all  of which  involve 
cell-matrix interactions via cell surface matrix receptors. 
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